The lipolytic enzyme hepatic lipase (HL) may facilitate mobilization of cholesterol substrate for ovarian steroidogenesis. We investigated whether HL was necessary for optimum reproduction in the female mouse by analyzing breeding performance and ovarian responses to gonadotropins in HLϪ/Ϫ mice. HLϪ/Ϫ female mice bred with HLϪ/Ϫ males had the same pregnancy success rate and pup survival rate as did wild-type (WT) mice but had significantly smaller litters, producing 1.7 fewer pups per litter. Mice were primed with eCG/hCG, and at 6 h posthCG the HLϪ/Ϫ mice had smaller ovaries than did the WT mice. HL deficiency specifically affected ovarian weight; adrenal gland weights did not differ between WT and HLϪ/Ϫ mice. HLϪ/Ϫ mice weighed more than age-matched WT mice. Between the two mouse genotypes, uterine weights were the same, indicating that estrogen production was equivalent. However, the HLϪ/Ϫ ovaries produced significantly less progesterone than did the WT ovaries within 6 h of hCG stimulation. HLϪ/Ϫ ovaries had the same number of large antral follicles as did the WT ovaries but had fewer hemorrhagic sites, which represent ovulations, fewer corpora lutea, and more oocytes trapped in corpora lutea. We suggest that reduced progesterone synthesis following hCG stimulation attenuated the final maturation of preovulatory follicles, resulting in smaller ovaries. Furthermore, reduced progesterone production limited the expression of proteolytic enzymes needed for tissue remodeling, resulting in fewer ovulations with a corresponding increase in trapped or unovulated oocytes and providing a possible explanation for the smaller litter size observed in spontaneously ovulating HLϪ/Ϫ mice.
INTRODUCTION
A major rate-limiting factor of steroidogenesis is the provision of cholesterol substrate. Insufficient cholesterol substrate can limit steroidogenesis even when other factors such as gonadotropin stimulation and expression of steroid biosynthetic enzymes are in place. Steroidogenic tissues rely on a combination of substrate sources to support steroidogenesis, including cholesterol uptake from plasma lipoproteins, mobilization of intracellular cholesteryl ester stores, and de novo cholesterol synthesis. 1 This work was supported by American Heart Association Predoctoral Awards 9804188P and 0010214Z (to R.L.W.) and American Heart Association Grant-in-Aid AGA6597 (to C.A.D.). C.A.D. is an Established Investigator of the American Heart Association.
The lipolytic enzyme hepatic lipase (HL) participates in providing cholesterol substrate for steroidogenesis. HL facilitates selective uptake and mobilization of cholesterol by hydrolyzing phospholipids and triglycerides of high-density lipoprotein (HDL) [1] , which is the primary source of plasma cholesterol for rodent steroidogenic tissues [2] . Both human and rodent steroidogenic tissues have two different forms of HL expressed from a single gene. Extracellular HL is a 59-kDa glycosylated enzyme expressed and secreted from parenchymal cells of the liver [3, 4] . The extracellular form is bound to heparan sulfate proteoglycans on the vascular endothelium of the liver and steroidogenic tissues, especially within corpora lutea of the ovary [5] . Recently, an intracellular form of HL was found to be expressed primarily in steroidogenic tissues [6] . The intracellular form is a 47-kDa enzyme that is expressed from the same gene as the full-length form but lacks the first two exons and signal sequence [7, 8] . In steroidogenic tissues, Ͼ90% of mRNA for HL codes for the truncated form; therefore, little to no full-length extracellular HL is made within these tissues [7] . The truncated HL retains the catalytic site that is present in the extracellular HL. The expression of extracellular and intracellular HL forms by steroidogenic tissues and their role in HDL metabolism suggest that HL participates in providing cholesterol to support steroidogenesis.
Many studies have indicated that both the extracellular and intracellular forms of HL are involved directly in ovarian steroidogenesis, although the relative contribution of each form remains unclear. HL enzymatic activity of ovary homogenate (containing both the extracellular and intracellular HL forms) is correlated with progesterone production during the rat estrous cycle, with highest activity localized within the corpora lutea during lactation and pseudopregnancy [9] . Release of the extracellular HL by heparin perfusion decreased HL activity by 25%-70%, suggesting that total HL activity in the ovary relies on the contribution of both the extracellular and intracellular forms of HL [10] . Total HL activity was increased several fold in superovulated rats, but antibody inhibition of the extracellular HL did not affect progesterone production [11] , suggesting that the intracellular HL may play a significant role in steroidogenesis. Vieira-van Bruggen et al. [12] showed that expression of truncated HL mRNA and intracellular HL protein was increased several fold in ovaries of eCG/hCGsuperovulated rats, again suggesting the potential importance of the intracellular HL to ovarian steroidogenesis. These experimental observations indicate that both the extracellular and intracellular forms of HL are involved in ovarian steroidogenesis, but what impact, if any, HL has on reproductive success has been untested. In the study presented here, we used a genetically modified mouse strain lacking the HL gene (HLϪ/Ϫ) and thus lacking the expression of both the intracellular and extracellular forms of HL, allowing us to address whether HL is necessary for optimum female reproductive performance.
MATERIALS AND METHODS

Breeding Protocol and Assessment of Reproductive Success
Breeding pairs of wild-type (WT) and HLϪ/Ϫ C57BL/6J mice were purchased from the Jackson Laboratory (Bar Harbor, ME). All mice were housed in the Northern Arizona University Animal Care Facility and treated according to an animal protocol approved by the Northern Arizona University Institutional Animal Care and Use Committee in compliance with the National Research Council Guide for Care and Use of Laboratory Animals. Mice were kept on a 12L:12D cycle at 25ЊC with free access to food and water. Males and females were housed individually except during breeding, which began at 7 wk of age. Breeding pairs were housed together for 2 wk and then separated. Females were observed daily following separation for the presence of pups, and the date of birth and number of pups born were recorded for each female. Pups were weaned at 29 days of age, and the number of surviving pups and the litter sex ratio was recorded. One week after pups were weaned, the mothers were bred to a different male. This breeding regimen resulted in females being bred approximately once every 2 mo. Females were bred until they did not become pregnant (no pups for 4 wk following separation from the male) for two consecutive breedings. Pregnancy success was calculated for each female through the first four breedings as the number of litters produced/ number of attempted breedings. Pup mortality was calculated for each litter as the difference between the number of pups born and the number of pups weaned.
Response to Superovulatory Treatment
Immature WT and HLϪ/Ϫ mice were superovulated at 29 days of age. Each female received a 100-l i.p. injection containing 12 IU eCG (Calbiochem, La Jolla, CA) or sterile saline. The time of eCG injection was considered 0 h. Forty-eight hours post-eCG, the mice received a second 100-l i.p. injection of 20 IU hCG (National Institutes of Health, Washington, DC) or sterile saline. There were three treatment groups: 1) salineinjected WT mice, 2) eCG/hCG-injected WT mice, and 3) eCG/hCG-injected HLϪ/Ϫ mice. Animals were killed by carbon dioxide inhalation followed by cervical dislocation at 3, 6, 12, or 24 h post-eCG and at 3, 6, 12, 24, 48, or 72 h post-hCG. At least two saline-injected WT mice, five superovulated WT mice, and five superovulated HLϪ/Ϫ mice were killed at each time point.
Plasma collection. Trunk blood was collected from each mouse into a heparinized 1.5-ml microcentrifuge tube and stored at 4ЊC until centrifugation. Within 1 h of collection, the blood samples were centrifuged at 10 000 rpm for 10 min at 4ЊC. The plasma fraction was removed and stored at Ϫ80ЊC until further processing.
Tissue collection. One randomly selected ovary from each animal was rapidly removed, trimmed of fat, snap frozen in liquid nitrogen, and stored at Ϫ80ЊC for ovary weight and hemorrhage site determination. Some of the remaining ovaries were fixed in Bouin solution (Sigma Chemical Co., St. Louis, MO) and embedded in paraffin, and others were snap frozen and stored at Ϫ80ЊC for RNA extractions. A small piece of liver was also removed from some animals and snap frozen for RNA extraction. The uteri and adrenal glands from each mouse were removed, trimmed, and placed into preweighed microcentrifuge tubes for weight determination.
Ovary weight and hemorrhagic site determination. The ovaries frozen for weight and hemorrhagic site determination were thawed at room temperature. The ovaries were placed into preweighed microcentrifuge tubes and reweighed. After weighing, each ovary was examined under a dissecting microscrope, and the number of hemorrhagic sites was recorded. The number of hemorrhagic sites per microgram of ovary was also calculated.
Ovarian sections. Ovaries removed at 24 h post-eCG and at 72 h posthCG were embedded in paraffin, serially sectioned at 7 m, and stained with hemotoxylin and eosin. Every 15th ovarian section (to avoid doublecounting ovarian structures) was examined by observers who were blinded to time point, hormone treatment, and mouse genotype. The number of large antral follicles, corpora lutea, and oocytes trapped within corpora lutea was recorded for each section.
Progesterone RIA. Steroids were ether extracted from the plasma samples. Recovery from the extraction was determined by calculating the percentage recovery of a 3 H-progesterone internal standard added to the plasma prior to extraction. Progesterone content of the extracted plasma samples was measured by specific RIA as described previously [13] . RIA results were calculated by a four-parameter logistic analysis using the software AssayZap (Biosoft, Ferguson, MO) and adjusted for extraction recovery.
Reverse transcriptase-polymerase chain reaction for HL. Total ovarian and liver RNA was prepared from frozen tissues using an RNeasy Mini RNA Extraction Kit (Qiagen, Valencia, CA). One microgram of total RNA, with a 260/280 absorbance ratio of Ͼ1.5 as determined by spectrophotometric reading, was used for a reverse transcriptase-polymerase chain reaction (RT-PCR) assay as described previously [14] . Specific oligonucleotide primers were designed from the reported cDNA sequence for mouse hepatic lipase (GenBank accession X58426). The forward primer sequence included nucleotides 673-690: 5Ј-GGACGCCATTCATACCTT-3Ј, and the reverse primer sequence included nucleotides 1246-1263: 5Ј-ATCAACTCGCCGATGTCT-3Ј (Operon Technologies, Alameda, CA). These primers were used to amplify a 591-base pair (bp) product from a region of the cDNA common to both the extracellular and intracellular forms of HL [6] . The amplified product was visualized by gel electrophoresis using a 1.2% agarose (Sigma) gel. The size of the product was estimated by comparison to a DNA ladder (Hi-Low DNA Ladder; Minnesota Molecular, Minneapolis, MN) using the Electrophoresis Documentation and Analysis System 120 and 1D Image Analysis Software (Kodak Digital Science, Rochester, NY). To confirm the identity of the PCR product, it was purified using a QIAquick PCR Purification Kit (Qiagen) and digested with the restriction enzyme Pst1 (New England Biolabs, Beverly, MA). The resulting fragments were visualized by gel electrophoresis, and their sizes were estimated as described above.
Statistical Analysis
Means for litter size, percentage of pups surviving, pup weight, number of hemorrhagic sites/g ovary, and number of large antral follicles, corpora lutea, and trapped oocytes were compared between WT and HLϪ/Ϫ mice using a Student t-test. The number of successful matings was compared between WT and HLϪ/Ϫ mice using a chi-square test. Means for number of hemorrhagic sites, ovary weight, adrenal weight, uterine weight, and serum progesterone concentration were compared across time points between saline-injected WT, superovulated WT, and superovulated HLϪ/Ϫ mice using a two-way ANOVA. Differences were assumed to be significant at P Ͻ 0.05.
RESULTS
Hepatic Lipase Is Expressed in the Mouse Ovary
In all previous studies of HL, rat tissues have been used, so we first confirmed that HL mRNA is expressed in the mouse liver and ovary. We used RT-PCR with specific primers that recognized both the extracellular and intracellular forms to detect HL expression in both liver and ovary tissue from superovulated WT mice. We amplified a product of the expected length of 591 bp from both liver and ovary tissue ( Fig. 1 ) and used restriction digest analysis to verify that the product represented the HL cDNA sequence (data not shown). These results confirmed that HL mRNA is expressed in mouse in both the liver and ovary.
Hepatic Lipase Deficiency Resulted in Significantly Reduced Litter Size
To determine whether HL plays a significant role in reproduction, we compared reproductive performance of WT and HLϪ/Ϫ females through their first four breedings. Pregnancy success did not differ significantly between WT and HLϪ/Ϫ females ( 2 test, P Ͼ 0.05; Table 1 ). However, HL Ϫ/Ϫ females had significantly smaller litters than did WT females (Student t-test, P Ͻ 0.05; Table 1 ), producing on average 1.7 fewer pups per litter. Although fewer pups were produced, HLϪ/Ϫ pups did not have greater mortality compared with WT pups (Student t-test, P Ͼ 0.05; Table  1 ), suggesting that HL deficiency does not affect postpartum pup survival. The results showed that HL deficiency reduced optimal reproductive performance. 
Hepatic Lipase Deficiency Resulted in Smaller Ovaries after hCG Treatment
We used eCG/hCG hormone stimulation to synchronize ovarian responses and compared the weights of the ovaries from the three treatment groups to estimate follicular development. Throughout the superovulation regimen, the salinetreated WT ovaries remained small and unchanged in weight; therefore, all time points were combined (Fig. 2, open bar) . In contrast, the eCG/hCG-treated WT and HLϪ/Ϫ mice showed significant increases in ovary weight (20%-80%) throughout the superovulation regimen (Fig. 2 , saline control vs. eCG/hCG-treated animals, two-way ANOVA, P Ͻ 0.05). During the post-eCG/pre-hCG time frame, ovarian weight did not differ significantly between WT and HLϪ/Ϫ mice (Fig.  2 , post-eCG/pre-hCG time points, two-way ANOVA, P Ͼ 0.05), suggesting that follicular development and maturation were unaffected by HL deficiency during early and middle stages of the induced follicular phase. However, eCG/hCGtreated HLϪ/Ϫ ovaries were significantly smaller than WT ovaries during the post-hCG phase of the regimen (Fig. 2 , post-hCG time points, two-way ANOVA, P Ͻ 0.05). The most dramatic differences occurred during the first 12 h and 72 h post-hCG injection when eCG/hCG-treated HLϪ/Ϫ ovaries were 20%-40% smaller than WT ovaries.
Effects of Hepatic Lipase Deficiency on Weight Were Specific to the Ovary
Two hypotheses were proposed to explain decreased ovary weight in HLϪ/Ϫ mice: 1) reduced total body weight resulting in smaller ovaries or 2) smaller steroidogenic tissues due to a developmental impact of HL deficiency. To examine the first hypothesis, we compared body weights of 19-and 29-day-old WT and HLϪ/Ϫ mice. At 19 days, body weight did not differ significantly between WT and HLϪ/Ϫ pups (Fig. 3 , Student t-test, P Ͼ 0.05), but at 29 days (the first day of the eCG injection), HLϪ/Ϫ mice weighed significantly more (ϳ8%) than WT mice (Fig. 3 , Student t-test, P Ͻ 0.05). If the larger overall body size of the HLϪ/Ϫ mice at the time of superovulation were factored in, the differences in ovarian weights between WT and HLϪ/Ϫ mice (Fig. 2) would be even more pronounced.
To determine whether HL deficiency had a developmental impact on another steroidogenic tissue, we compared adrenal glands of saline-treated WT and eCG/hCG-treated WT and HLϪ/Ϫ mice throughout the superovulation regimen. Adrenal gland weights did not differ across time points of the superovulation regimen nor between WT and HLϪ/Ϫ mice with or without the eCG/hCG treatment (twoway ANOVA, P Ͼ 0.05; Table 2 ). Together, these results suggested that the effects of HL deficiency are specific to the ovary and not due to developmental differences between WT and HLϪ/Ϫ mice.
Hepatic Lipase Deficiency Did Not Influence Uterine Growth
To examine the role of HL in gonadotropin-induced steroid production, we compared estrogen-sensitive uterine weights of saline-treated WT and eCG/hCG-treated WT and HLϪ/Ϫ mice. As expected eCG/hCG treatment stim -FIG. 3 . HLϪ/Ϫ pups weighed more than WT pups. The weights of WT (n ϭ 30) and HLϪ/Ϫ (n ϭ 78) pups were recorded at 19 and 29 days of age. The data are presented as the mean Ϯ SEM, and the differences in weight were analyzed with separate Student t-tests. Significant differences (P Ͻ 0.05) between WT and HLϪ/Ϫ pups and the direction of the differences are denoted in the figure by inequality (Ͻ or Ͼ) symbols. Nonsignificant differences are denoted by an equality symbol (ϭ). a Significant difference (P Ͻ 0.05) between saline-treated and eCG/hCGtreated mice.
FIG. 4.
Ovarian progesterone production by HLϪ/Ϫ mice was less than that by WT mice just after hCG treatment. The plasma progesterone concentrations of saline-treated WT or eCG/hCG-treated WT and HLϪ/Ϫ mice 3-24 h post-eCG injection and 3-72 h post-hCG injection are presented as the mean (n Ն 5 animals) Ϯ SEM. Differences in serum progesterone concentration among the three treatment groups were analyzed across the post-eCG/pre-hCG time points and across the post-hCG time points with separate two-way ANOVAs. Significant differences (P Ͻ 0.05) and the direction of the differences between the treatment groups are denoted in the figure by inequality (Ͻ or Ͼ) symbols. Nonsignificant differences are denoted by an equality symbol (ϭ).
ulated uterine growth throughout the superovulation regimen (two-way ANOVA, treatment effect, P Ͻ 0.05, data not shown), but there was no significant difference between WT and HLϪ/Ϫ mice (two-way ANOVA, genotype effect, P Ͼ 0.05; Table 2 ). These data were consistent with the lack of difference in ovarian weights between WT and HLϪ/Ϫ mice at 24 h post-eCG ( Fig. 2) and suggest that estrogen production by developing follicles was not influenced by the absence of HL.
Hepatic Lipase Deficiency Attenuated Post-hCG Progesterone Production
Plasma progesterone was measured by specific RIA and compared among saline-treated WT and eCG/hCG-treated WT and HLϪ/Ϫ mice. Plasma progesterone remained low and unchanged in saline-treated WT animals throughout the stimulation regimen. Therefore, all time points were combined (Fig. 4, open bar) . Progesterone levels in the eCG/ hCG-treated WT and HLϪ/Ϫ mice were not significantly different from those of saline-treated WT mice during the post-eCG/pre-hCG phase (Fig. 4 , two-way ANOVA, posteCG time points, P Ͼ 0.05), which was expected because progesterone is not the major steroid product during the early and middle follicular phases of growth. In contrast, by 3 h post-hCG, progesterone levels in both the WT and HLϪ/Ϫ mice were significantly increased (2-to 8-fold) compared with saline-injected WT mice (Fig. 4 , saline vs. eCG/hCG-treated animals, two-way ANOVA, P Ͻ 0.05). By 72 h post-hCG, progesterone production in both WT and HLϪ/Ϫ mice had returned to the levels in the salineinjected WT mice. After hCG, the HLϪ/Ϫ mice produced significantly less progesterone than did the WT mice (Fig.  4 , two-way ANOVA, post-hCG time points, P Ͻ 0.05). These differences were most dramatic within the first 6 h following hCG and at 48 h post-hCG, when HLϪ/Ϫ mice produced 25%-40% less progesterone than did WT mice.
HLϪ/Ϫ Ovaries Ovulated Fewer Oocytes than Did WT Ovaries
To determine whether HL plays a role in ovulation, we compared the number of ovarian hemorrhagic sites in saline-treated WT and eCG/hCG-treated WT and HLϪ/Ϫ mice. As expected, immature saline-treated WT ovaries did not have hemorrhagic sites. Both eCG/hCG-treated WT and HLϪ/Ϫ ovaries had hemorrhagic sites after hCG treatment. However, eCG/hCG-treated HLϪ/Ϫ ovaries had significantly fewer hemorrhagic sites than did eCG/hCG-treated WT ovaries, ranging from 1 to 7 fewer hemorrhagic sites after hCG treatment (Fig. 5 , two-way ANOVA, P Ͻ 0.05). When the number of hemorrhagic sites was normalized to ovarian weight and averaged over the entire post-hCG time course, the HLϪ/Ϫ ovaries had about half of the hemorrhagic sites per microgram of ovary than did WT ovaries (Fig. 6 , Student t-test, P Ͻ 0.05).
HLϪ/Ϫ Ovaries Had More Trapped Oocytes in Corpora Lutea
Given reduced progesterone production and fewer ovulated oocytes in response to eCG/hCG in HLϪ/Ϫ ovaries, we anticipated that there would be more trapped oocytes in corpora lutea that represented unruptured follicles. When we examined the ovarian sections, the number of large antral follicles did not differ significantly between WT and HLϪ/Ϫ ovaries examined at 24 h post-eCG (Table 3) . However, the number of corpora lutea was significantly lower in HLϪ/Ϫ ovaries than in WT ovaries at 72 h posthCG. There were 3 times as many oocytes trapped within corpora lutea in eCG/hCG-treated HLϪ/Ϫ ovaries than in WT ovaries at 72 h post-hCG (Table 3 , Student t-test, P Ͻ 0.05).
DISCUSSION
The absence of HL had a subtle but profound impact on reproductive performance in female mice. The HLϪ/Ϫ mice averaged 1.7 fewer pups per litter than did the WT mice. We suspected that the smaller litters were the result of reduced ovarian steroid production due to the absence of HL. To test this hypothesis, we used an eCG/hCG treatment regimen to synchronize the responses of the ovary and to cause a supraphysiologic stimulation, anticipating that a greater demand on ovarian steroidogenesis would reveal a greater discrepancy between the responses of the HLϪ/Ϫ and WT mice. This prediction was true; there was a 22% reduction in ovulated oocytes (based on the reduced number of pups per litter) in the spontaneously cycling ovaries but almost a 50% decrease in ovulated oocytes in the eCG/hCG-treated HLϪ/Ϫ ovaries. The HLϪ/Ϫ and WT ovarian responses differed dramatically within 6 h of hCG stimulation; the HLϪ/Ϫ ovaries were smaller, had fewer hemorrhagic sites or ovulations and fewer corpora lutea, and contained more trapped oocytes. These differences were likely due to the significant decrease in progesterone production in the HLϪ/Ϫ mice that also occurred within 6 h of hCG injection. Although progesterone was lower in HLϪ/Ϫ mice just after the hCG injection, estrogen production as indicated by uterine weight gains was not different between the genotypes. Thus, in the absence of HL, ovarian production of progesterone but not estrogen was significantly reduced, leading to a reduced ovulatory rate.
Because all steroids come from cholesterol, why was it that in the absence of HL progesterone production was reduced without altering estrogen levels? Estrogen production is regulated by the amount of androgen substrate synthesized by the theca cells. Theca cells are well vascularized and have ready access to HDL to meet their cholesterol demand. Therefore, what limits androgen production in theca cells is the level of expression of P450 17␣-hydroxylase, C 17-20 lyase, the enzyme that converts pregnenolone and progesterone into testosterone and androstenedione, respectively. Consequently, estrogen production is indirectly related to the amount of progesterone available for conversion into androgen. In contrast, progesterone production by cells luteinizing in response to the LH surge is limited by the amount of available cholesterol substrate. Without HL, the reduced progesterone production was likely due to less cholesterol substrate being made available for utilization. Also, estrogen peaks at levels in the picograms per milliliter range in plasma. However, during the extreme steroidogenic demand of the LH surge, progesterone levels reach high levels, in the nanograms per milliliter range, in plasma so that up to 1000-fold increase in cholesterol substrate is needed to support the dramatic increase in progesterone in the plasma.
After hCG treatment, HLϪ/Ϫ ovaries weighed signifi-cantly less than WT ovaries. The ovaries in HLϪ/Ϫ mice were smaller apparently because of their attenuated response to gonadotropin stimulation. There were fewer corpora lutea in the HL-deficient ovaries, so when these corpora lutea regressed there was a more dramatic drop in ovarian weight in the HLϪ/Ϫ ovaries than in the WT ovaries at 72 h after the hCG dose. Decreased ovarian weight in the HLϪ/Ϫ mice was not attributed to developmental deficiencies or general deficits in steroidogenic tissues. Age-matched HLϪ/Ϫ mice weighed more than their WT counterparts. If an allometric adjustment were factored in for the greater HLϪ/Ϫ body size, the post-hCG HLϪ/Ϫ ovaries would be even smaller, relatively, than those of matched WT ovaries. The adrenal gland weights in each of the 2 genotypes were equivalent. Yet another potential explanation for the smaller HLϪ/Ϫ ovaries was the development of fewer antral follicles in response to eCG, so when hCG was injected fewer follicles were ready to respond with their final growth phase. However, this explanation was not supported; the numbers of large antral follicles in the HLϪ/Ϫ ovaries was the same as that in the WT ovaries following eCG priming. These data suggest that the HLϪ/Ϫ ovaries were smaller after the hCG injection because of the attenuation of late-stage progesteronedependent follicular maturation. Progesterone is essential for the final maturation of preovulatory follicles that follows the LH surge [15] . If fewer ovulations in HLϪ/Ϫ ovaries were due only to reduction of final follicular growth, then normalizing the number of hemorrhagic sites to ovary weight should eliminate the difference between the strains. Despite normalizing the number of hemorrhagic sites to ovary weight, eCG/hCG-treated HLϪ/Ϫ mice still had significantly fewer hemorrhagic sites. Thus, these results suggest that in addition to decreasing hCG-dependent follicular growth, HL deficiency may have also led to impaired release of the oocytes. This conclusion was supported by the observation that eCG/hCGtreated HLϪ/Ϫ ovaries had significantly more oocytes trapped in corpora lutea and fewer corpora lutea than did WT ovaries. Trapped oocytes have been reported in eCG/ hCG-stimulated progesterone receptor-deficient mice, which cannot successfully ovulate in spite of having preovulatory follicles [16] .
Successful ovulation requires the physical release of the mature oocyte. Expulsion of the oocyte is dependent on progesterone induction of proteolytic enzymes that degrade the follicle wall [17] . The dependence on progesterone for ovulation has been demonstrated by using anti-progesterone antiserum [18] , blocking progesterone production [19] , and blocking the progesterone receptor with antagonists [20, 21] and in studies with anovulatory progesterone receptor-deficient mice [22] . Two proteases, A disintegrin and metalloproteinase with thrombospondin-like motifs (ADAMTS-1), and cathepsin L, a lysosomal cysteine protease, are transcriptional targets of the progesterone receptor, and both are induced by LH-stimulated progesterone produced prior to ovulation [17] . We suggest that the reduced production of progesterone in the HLϪ/Ϫ ovaries that occurred just after hCG stimulation resulted in reduced expression of proteases needed for the degradation of the walls of all of the preovulatory follicles ready to release their oocytes.
HL expression is greatest in the luteinized rat ovary and is dramatically higher in superovulated rat ovaries [11] . Additionally, expression of mRNA for the truncated HL parallels progesterone production in superovulated rats [12] . Our observation that HL deficiency results in decreased progesterone production just after hCG stimulation is consistent with these previous results, but exactly how and which form of HL supports ovarian steroidogenesis remains unclear. Gonadotropin-stimulated steroidogenesis is dependent on the availability of cholesterol substrate. HL probably participates in steroidogenesis by facilitating the provision of cholesterol substrate.
In vitro and in vivo extracellular HL facilitates selective uptake of cholesteryl esters from HDL via scavenger receptor class B, type I (SR-BI) [23] [24] [25] [26] . Extracellular HL enhances selective uptake by acting both as a ligand for HDL and as a lipolytic enzyme, remodeling the HDL particle to promote cholesteryl ester transfer. SR-BI and HL are coparticipants in steroidogenesis, as indicated by the upregulation of SR-BI mRNA expression in HLϪ/Ϫ mouse adrenal gland [27] . Also, inhibition of extracellular HL by blocking antibodies causes significant increases in adrenal SR-BI expression similar to the compensatory response in HLϪ/Ϫ mouse adrenal gland [28] . Thus, in the absence of HL ovarian selective uptake of cholesteryl esters by SR-BI may have been significantly compromised, limiting progesterone production and diminishing ovarian responses distal to progesterone production. The dependence on extracellular HL to support steroidogenesis may differ in the mouse because in mice two thirds of the HL activity is in plasma, whereas in rats and humans HL activity is undetectable in plasma [29] .
It is unknown whether the expression of ovarian HL is altered by the absence of SR-BI. SR-BI-deficient mice have been generated, but study of HL expression and its participation in facilitating selective uptake by steroidogenic tissues in these mice has not been reported. SR-BI-deficient female mice are infertile [30] . Pseudopregnant SR-BI-deficient mice have levels of serum progesterone 6 days after superovulation similar to those of control WT mice [30] . The SR-BI-deficient mice have no obvious defects in their estrous cycles or number of oocytes ovulated [30] . However, a detailed study of ovarian progesterone production within 12 h of hCG injection, the time frame in our studies when the absence of HL resulted in a significant decrease in progesterone production, has not been reported for SR-BI-deficient mice.
The role of the truncated intracellular HL in ovarian steroidogenesis is undefined. The truncated HL may also be involved with SR-BI in facilitating cholesteryl ester transfer from HDL or in the management of the transfer of phospholipids. Intracellular HL may facilitate the mobilization of cholesterol from cholesteryl ester-rich lipid droplets that are so prominent in steroidogenically active ovarian cells, a role that was previously suggested by Vieira-van Bruggen et al. [12] . The pattern of immunolocalized HL in the WT mouse adrenal gland is similar to that seen when lipid vesicles in the cells are stained with oil red O [31] . Thus, without intracellular HL there may be less efficient use of cholesteryl ester stores needed during periods of extreme demand, such as in response to the LH surge or the supraphysiologic hCG-mediated stimulation of progesterone production. Another scenario could involve HL in the processing of HDL as it is routed through the newly described retroendocytic pathway, which has been shown to occur with HDL selective uptake by the liver via SR-BI [32, 33] .
HL deficiency in the mouse results in a mild dyslipidemia with an increased subfraction of larger, less dense HDL particles [34] . These large cholesterol-rich HDL particles are less efficient at supporting ovarian steroidogenesis [35] . Thus, the in vivo decrease in ovarian progesterone production could have been due to HDL subfraction differences in the HLϪ/Ϫ mice. An in vitro investigation of HLϪ/Ϫ ovarian cell steroidogenesis could differentiate between the contribution of altered HDL and that of HL deficiency to abnormalities in ovarian function.
HL deficiency occurs in humans and is associated with a more profound dyslipidemia than that observed in the HLϪ/Ϫ mouse [36] . It is not known whether HL-deficient women have compromised reproduction because the critical information, i.e., documented difficulty conceiving or maintaining pregnancy, has not been reported. Human ovaries produce very large quantities of progesterone shortly after the endogenous LH surge, on the order of a 5-fold increase in plasma concentration within the first 24 h [37] . Given the results presented here, we would expect that HL-deficient women would experience reproductive problems with fewer successful ovulations. Our findings indicate that HL, the extracellular or intracellular form or both forms, is required for optimal reproductive performance in the mouse.
